fibronectin; FN; cold-insoluble globulin; CIG; contains: anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3 (FN1, FN)
Jump to navigation
Jump to search
Function
- adhesive glycoproteins
- cell adhesion
- cell motility
- opsonization
- wound healing
- maintenance of cell shape
- component of the blood-brain barrier (very small amounts in healthy people)
- interaction with TNR mediates inhibition of cell adhesion & neurite outgrowth
- interacts with FBLN1, AMBP, TNR, LGALS3BP
Structure
- length: 60 nm, width: 2.5 nm
- contains 12 fibronectin type-1 domains
- contains 2 fibronectin type-2 domains
- contains 16 fibronectin F3 modules
- fibrin-binding domain of fibronectin facilitates cross- linking of fibrin to fibronectin catalyzed by coagulation factor XIII
- fibroblasts & other cells that repair the site of injury adhere to the clot by interacting with the cell-binding region of fibronectin in the clot.
- collagen-binding domain of fibronectin in connection with the cell surface adhesion site (binding site for fibronectin receptor) facilitates adherance of cells to collagen; both bindings are reversible facilitating movement of cells on collagen sufaces
- heparan sulfate-binding site of fibronectin in connection with the cell surface adhesion site (binding site for fibronectin receptor) facilitates adherance of cells to proteoglycans
- H2N-Fibrin-Collagen-E3B-RGD-E3A-V-Fibrin-COOH
Compartment
secreted, extracellular matrix
Alternative splicing
Expression
- plasma fibronectin (soluble dimeric form) is secreted by hepatocytes; when present in plasma are called cold insoluble globulins.
- cellular fibronectin (dimeric or cross-linked multimeric forms), made by fibroblasts, epithelial & other cell types, is deposited as fibrils in the extracellular matrix
- Ugl-Y1, Ugl-Y2 & Ugl-Y3 are found in urine (0-17 years of age)
Pathology
- fibronectin is lost or reduced when cells undergo viral or chemical transformation
- highly susceptible to proteolysis
- fibronectins accumulate in insoluble form in cartilage & insoluble form in synovial fluid in rheumatoid & osteoarthritis
- mutations in FN1 cause glomerulopathy with fibronectin deposits
- excess fibronectin may be present in the blood-brain barrier of patients with Alzheimer's disease*[9]
* a loss-of function variant of the fibronectin gene appears to prevent buildup of fibronectin in the blood-brain barrier[9]
Comparative biology
Notes
- from the Latin fibra (fiber) & necter (to bind or connect
More general terms
Additional terms
- CD49 or Very Late Antigen (VLA)
- fetal fibronectin in cervical-vaginal fluid
- glycoprotein IIB/IIIA
- scavenger receptor
References
- ↑ Baron M, Norman DG, Campbell ID. Protein modules. Trends Biochem Sci. 1991 Jan;16(1):13-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2053133
- ↑ Stryer Biochemistry WH Freeman & Co, New York, 1988 pg 277
- ↑ Clinical Guide to Laboratory Tests, 3rd edition, NW Tietz ed, WB Saunders, Philadelphia, 1995
- ↑ Peters JH, Carsons S, Yoshida M, Ko F, McDougall S, Loredo GA, Hahn TJ. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther. 2003;5(6):R329-39. Epub 2003 Sep 8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14680507
- ↑ Castelletti F et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci USA 2008;105:2538-2543 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18268355
- ↑ 6.0 6.1 White ES, Baralle FE, Muro AF. New insights into form and function of fibronectin splice variants. J Pathol. 2008 Sep;216(1):1-14. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18680111
- ↑ Wikipedia - fibronectin entry http://en.wikipedia.org/wiki/fibronectin
- ↑ UniProt http://www.uniprot.org/uniprot/P02751.html
- ↑ 9.0 9.1 9.2 9.3 Bhattarai P, Gunasekaran TI, Belloy ME et al Rare genetic variation in fibronectin 1 (FN1) protects against APOE(epsilon)4 in Alzheimer's disease. Acta Neuropathol. 2024 Apr 10;147(1):70. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38598053